Anthropometry in Gastroesophageal Reflux Disease and Esophageal Injury
Recruiting in Palo Alto (17 mi)
PG
Overseen byPrasad G Iyer, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Mayo Clinic
No Placebo Group
Trial Summary
What is the purpose of this trial?
Is waist to hip ratio (WHR), waist circumference (WC), (as markers of visceral adiposity) associated with an increase in acidic and non acidic reflux as well as systemic inflammation involving esophageal mucosa, thereby increasing esophageal injury and predisposing to subsequent development of Barrett's esophagus (BE)?
Research Team
PG
Prasad G Iyer, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
Subjects over the age of 18 undergoing clinically indicated 24 hour pH impedance and/or pH studies. Many will also undergo clinically indicated endoscopy, and consent for acquiring tissue samples for future biomarker staining tests will be obtained.
Able to give informed consent
Subjects with a prior history of esophageal surgery, or diagnosis of BE
Treatment Details
Interventions
- Anthropometry (Behavioural Intervention)
- Tissue samples (Procedure)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Anthropometric Measurements; Tissue SamplesExperimental Treatment2 Interventions
All participants will have their waist circumference and waist to hip ratio taken as a measurement of central obesity. Participants undergoing clinically indicated upper endoscopy and who consent to providing tissue samples will have 8 tissue samples taken for future research purposes.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Trials
3,427
Recruited
3,221,000+
Dr. Gianrico Farrugia
Mayo Clinic
Chief Executive Officer since 2019
MD from University of Malta Medical School
Dr. Richard Afable
Mayo Clinic
Chief Medical Officer
MD from Loyola Stritch School of Medicine